Skip to main content
. 2020 Nov 6;13:1756284820964316. doi: 10.1177/1756284820964316

Table 3.

Baseline characteristics of patients underwent endoscopic submucosal dissection and primary surgery for superficial esophageal squamous cell cancer.

Reference ESD Surgery p-value
Case number Min et al.,21 Zhang et al.,22 Yamauchi et al.29 Baisi et al.,30 Takeuchi et al.31 638 546
Age (median) Min et al.,21 Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 64.1 62.6 0.136
Sex (male %) Min et al.,21 Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 82.5 78.7 0.069
Lesion size (median, mm) Min et al.,21 Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 17–45 16–52 0.163
Location Min et al.,21 Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 0.842
 Upper 74 42 0.043*
 Middle 332 264 0.332
 Lower 176 189 0.687
Invasion depth Min et al.,21 Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 0.057
 T1a (mucosa) 425 207
 T1b (submucosa) 159 288
Lesions > 3/4 circumference (%) Baisi et al.,30 Takeuchi et al.31 21.8 44.5 <0.001*
Lymphovascular invasion (%) Min et al.,21 Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 7.7 15.3 0.132
Poorly differentiated (%) Min et al.,21 Baisi et al.,30 2.1 2.3 0.678
R0 resection (%) Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 89.8 97.0 <0.001*
Recurrence and metastasis (%) Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 9.4 12.2 0.646
Metachronous recurrence (%) Min et al.,21 Baisi et al.,30 7.4 0 0.028*
Procedure time (min, median) Zhang et al.22 53 240 <0.001*
Hospital stay (days) Zhang et al.,22 Baisi et al.30 4.3 12.2 0.02*
*

p < 0.05.

random-effects model owing to significant heterogeneity.

ESD, endoscopic submucosal dissection.